NFKB1 and malignant colon neoplasm: These, together with other reports [2, 8], suggest that the human T-lymphocyte cell line Jurkat and the human colon cancer cell line LoVo may have a common mechanism, glucocorticoids suppressing NF-κB activity via GR.